Form 4 Filing: GRIFFIN MICHELLE RENEE Sells $1.5M of $ADPT

INSIDER SALE

⚡ MATERIALITY: 6/10

corporate issuer

Adaptive Biotechnologies Corp

Ticker: $ADPT

Transaction Value

$1.5M

Price/Share: $13.99

transaction date

2026-06-25

Shares: 104,168

Market Price Activity

HillSignal AI Analytical Report

SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, GRIFFIN MICHELLE RENEE, holds the title of Director at Adaptive Biotechnologies Corp.

On 2026-06-25, the insider transacted 104,168 shares.The shares were transacted at a weighted average price of $13.99 per share, resulting in a total market-relevant value of $1.5M.

Executive Summary Summary

GRIFFIN MICHELLE RENEE (Director) sold $1.5M of $ADPT

Post-Transaction Position: 15,625 shares

SEC Accession No: 0001229765-26-000008 (CIK: 1229765)

Verified Multi-Source Index

Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.

SEC EDGAR FilingView Source Form 4

Yahoo Finance$ADPT Quote & Profile

OpenCorporates RegistryVerify Corporate Identity

Google News$ADPT News Coverage